Mustang Bio, Inc.
USD0.69
-0.01 (-1.39%)
CEO
Manuel Litchman
IPO Date
2017-08-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.66
Prev. Close
$0.70
Day Low
$0.66
Day High
$0.70
52W Low
$0.53
52W High
$7.00
Market Cap
$0.01B
Volume
0.01M
| 278,385 |
| $0.00 |
| 30 Dec 2025 | Herskowitz Neil | director | S-Sale | Disposed | 247 | $0.96 |
| 30 Dec 2025 | Chill Adam J. | director | S-Sale | Disposed | 4 | $0.95 |
| 30 Dec 2025 | Jin David | director | P-Purchase | Acquired | 247 | $0.96 |
| 1 Oct 2025 | Fortress Biotech, Inc. | 10 percent owner | A-Award | Acquired | 59,334 | $0.00 |
| 28 Apr 2025 | Litchman Manuel MD | director, officer: President, CEO and Interim CFO | F-InKind | Disposed | 27 | $1.24 |
| 2 Apr 2025 | Fortress Biotech, Inc. | 10 percent owner | A-Award | Acquired | 67,806 | $0.00 |
| 3 Jan 2025 | Fortress Biotech, Inc. | 10 percent owner | Disposed | 0 | $0.00 |
| 28 Jun 2024 | Fortress Biotech, Inc. | 10 percent owner | A-Award | Acquired | 575,191 | $0.00 |